DURVALUMAB

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Approval Year

Substance Class	Protein Created by `admin` on `Sat Dec 16 08:41:27 UTC 2023` Edited by `admin` on `Sat Dec 16 08:41:27 UTC 2023`
Protein Type	MONOCLONAL ANTIBODY
Protein Sub Type	IGG1
Sequence Origin	HUMAN
Sequence Type	COMPLETE
Record UNII	28X28X9OKV
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

DURVALUMAB

Official Name

English

DURVALUMAB [USAN]

Common Name

English

IMFINZI

Brand Name

English

DURVALUMAB [JAN]

Common Name

English

MEDI-4736

Code

English

durvalumab [INN]

Common Name

English

DURVALUMAB [PURPLE BOOK CDER]

Common Name

English

IMMUNOGLOBULIN G1, ANTI-(HUMAN PROTEIN B7-H1) (HUMAN MONOCLONAL MEDI4736 HEAVY CHAIN), DISULFIDE WITH HUMAN MONOCLONAL MEDI4736 .KAPPA.-CHAIN, DIMER

Common Name

English

DURVALUMAB [MI]

Common Name

English

MEDI4736

Code

English

Durvalumab [WHO-DD]

Common Name

English

IMMUNOGLOBULIN G1, ANTI-(HUMAN CD ANTIGEN CD274) (HUMAN MONOCLONAL MEDI4736 HEAVY CHAIN), DISULFIDE WITH HUMAN MONOCLONAL MEDI4736 .KAPPA.-CHAIN, DIMER

Common Name

English

Classification Tree Code System Code

WHO-ATC

L01XC28

Created by admin on Sat Dec 16 08:41:27 UTC 2023 , Edited by admin on Sat Dec 16 08:41:27 UTC 2023

NDF-RT

N0000193338

Created by admin on Sat Dec 16 08:41:27 UTC 2023 , Edited by admin on Sat Dec 16 08:41:27 UTC 2023

FDA ORPHAN DRUG

785220

Created by admin on Sat Dec 16 08:41:27 UTC 2023 , Edited by admin on Sat Dec 16 08:41:27 UTC 2023

NCI_THESAURUS

C128057

Created by admin on Sat Dec 16 08:41:27 UTC 2023 , Edited by admin on Sat Dec 16 08:41:27 UTC 2023

FDA ORPHAN DRUG

721519

Created by admin on Sat Dec 16 08:41:27 UTC 2023 , Edited by admin on Sat Dec 16 08:41:27 UTC 2023

FDA ORPHAN DRUG

691319

Created by admin on Sat Dec 16 08:41:27 UTC 2023 , Edited by admin on Sat Dec 16 08:41:27 UTC 2023

Code System Code Type Description

DAILYMED

28X28X9OKV

Created by admin on Sat Dec 16 08:41:27 UTC 2023 , Edited by admin on Sat Dec 16 08:41:27 UTC 2023

PRIMARY

INN

10010

Created by admin on Sat Dec 16 08:41:27 UTC 2023 , Edited by admin on Sat Dec 16 08:41:27 UTC 2023

PRIMARY

EVMPD

SUB176342

Created by admin on Sat Dec 16 08:41:27 UTC 2023 , Edited by admin on Sat Dec 16 08:41:27 UTC 2023

PRIMARY

LACTMED

Durvalumab

Created by admin on Sat Dec 16 08:41:27 UTC 2023 , Edited by admin on Sat Dec 16 08:41:27 UTC 2023

PRIMARY

CAS

1428935-60-7

Created by admin on Sat Dec 16 08:41:27 UTC 2023 , Edited by admin on Sat Dec 16 08:41:27 UTC 2023

PRIMARY

WIKIPEDIA

Durvalumab

Created by admin on Sat Dec 16 08:41:27 UTC 2023 , Edited by admin on Sat Dec 16 08:41:27 UTC 2023

PRIMARY

NCI_THESAURUS

C103194

Created by admin on Sat Dec 16 08:41:27 UTC 2023 , Edited by admin on Sat Dec 16 08:41:27 UTC 2023

PRIMARY

FDA UNII

28X28X9OKV

Created by admin on Sat Dec 16 08:41:27 UTC 2023 , Edited by admin on Sat Dec 16 08:41:27 UTC 2023

PRIMARY

RXCUI

1919503

Created by admin on Sat Dec 16 08:41:27 UTC 2023 , Edited by admin on Sat Dec 16 08:41:27 UTC 2023

PRIMARY

USAN

AB-135

Created by admin on Sat Dec 16 08:41:27 UTC 2023 , Edited by admin on Sat Dec 16 08:41:27 UTC 2023

PRIMARY

ChEMBL

CHEMBL3301587

Created by admin on Sat Dec 16 08:41:27 UTC 2023 , Edited by admin on Sat Dec 16 08:41:27 UTC 2023

PRIMARY

DRUG BANK

DB11714

Created by admin on Sat Dec 16 08:41:27 UTC 2023 , Edited by admin on Sat Dec 16 08:41:27 UTC 2023

PRIMARY

MERCK INDEX

m12004

Created by admin on Sat Dec 16 08:41:27 UTC 2023 , Edited by admin on Sat Dec 16 08:41:27 UTC 2023

PRIMARY

DRUG CENTRAL

5234

Created by admin on Sat Dec 16 08:41:27 UTC 2023 , Edited by admin on Sat Dec 16 08:41:27 UTC 2023

PRIMARY

SMS_ID

100000162511

Created by admin on Sat Dec 16 08:41:27 UTC 2023 , Edited by admin on Sat Dec 16 08:41:27 UTC 2023

PRIMARY

From	To
1_22	1_96
1_148	1_204
1_224	3_215
1_230	2_230
1_233	2_233
1_265	1_325
1_371	1_429
2_22	2_96
2_148	2_204
2_224	4_215
2_265	2_325
2_371	2_429
3_23	3_89
3_135	3_195
4_23	4_89
4_135	4_195

Glycosylation Type

MAMMALIAN

Glycosylation Link Type	Site
N	1_301
N	2_301

Related Record Type Details


					L4766ELH5T

PROGRAMMED CELL DEATH 1 LIGAND 1

TARGET -> INHIBITOR

Interaction Type:

BINDING

Related Record Type Details


					28X28X9OKV

ACTIVE MOIETY

Name	Property Type	Amount	Referenced Substance	Defining	Parameters	References
Molecular Formula	CHEMICAL
MOL_WEIGHT:NONGLYCOSYLATED	CHEMICAL
Biological Half-life	PHARMACOKINETIC

Volume of Distribution	PHARMACOKINETIC